Nivolumab and Temozolomide Versus Temozolomide Alone in Newly Diagnosed Elderly Patients With GBM
Condition: Glioblastoma Multiforme Interventions: Drug: Nivolumab; Drug: Temozolomide Sponsors: University of Sydney; Cooperative Trials Group for Neuro-Oncology; National Health and Medical Research Council, Australia Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials